Core Insights - Zimmer Biomet Holdings, Inc. has appointed Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer, reporting to President and CEO Ivan Tornos [1][2] Group 1: Leadership and Responsibilities - Jehanzeb Noor will lead strategy development and execution, oversee M&A activities including the integration of the pending acquisition of Paragon 28, and manage research and product development organizations [2] - Noor will also serve as Chief of Staff to the CEO, indicating a significant role in the company's strategic direction [2] Group 2: Background and Experience - Prior to joining Zimmer Biomet, Noor was President and Managing Director for Europe, Africa, and Asia at Trivium, where he focused on operational excellence and margin expansion [3] - Noor has held various leadership roles, including CEO of Smiths Medical and positions at Amcor, McKinsey, Ford Motor Company, and Constellation Energy Commodities Group [3] Group 3: Educational Qualifications - Jehanzeb Noor holds a Master of Science in Product Development, a Bachelor of Science in Finance, and a Bachelor of Science in Mechanical Engineering, all from the Massachusetts Institute of Technology (MIT) [4] Group 4: Company Overview - Zimmer Biomet is a global leader in medical technology, focusing on maximizing mobility and improving health through innovative products and integrated digital and robotic technologies [5][6] - The company has over 90 years of experience and is committed to delivering high-quality solutions to patients and providers [6]
Zimmer Biomet Appoints Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer